Cost-Effectiveness Analysis of Obinutuzumab Associated to Chlorambucil for the Treatment of Slow-Go Patients with Chronic Lymphocytic Leukemia (CLL) Under the Brazilian Public Healthcare System
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.2443
https://www.valueinhealthjournal.com/article/S1098-3015(17)32777-8/fulltext
Title :
Cost-Effectiveness Analysis of Obinutuzumab Associated to Chlorambucil for the Treatment of Slow-Go Patients with Chronic Lymphocytic Leukemia (CLL) Under the Brazilian Public Healthcare System
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)32777-8&doi=10.1016/j.jval.2017.08.2443
First page :
A855
Section Title :
BREAKOUT SESSIONS
Open access? :
No
Section Order :
2263